Falcon III Ventures is a Boston-based biotech venture capital firm focused on investing in innovative life sciences companies. Their mission is to support groundbreaking biotech startups that aim to revolutionize healthcare and improve patient outcomes. They provide funding, strategic guidance, and industry expertise to help these companies achieve their goals.
Falcon III Ventures has successfully backed several high-impact biotech startups, contributing to advancements in medical research and treatment. Their portfolio includes companies that have made significant strides in areas such as gene therapy, oncology, and personalized medicine.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Seed1 (100.0%)
Stage Mix
Seed 100%
Concentration shown as share of disclosed investments by stage.